What was the earnings per share (EPS) reported, and how does it align with analyst expectations?

Answer

The press‑release excerpt you provided does not contain the specific earnings‑per‑share (EPS) figure for MariMed’s second‑quarter 2025 results, nor does it mention how that EPS compares to analysts’ expectations.

To determine:

1. The reported EPS – you would need to locate the full earnings release (or the company’s earnings call transcript) where the EPS number is disclosed.
   
2. Alignment with analyst expectations – the comparison typically appears in the same release (e.g., “our EPS of $X.XX beat the consensus estimate of $Y.YY”) or can be derived from analyst consensus data published by financial data providers (e.g., Bloomberg, Refinitiv, FactSet) around the same date.

What to do next

• Visit the original press release on GlobeNewswire (or MariMed’s investor‑relations website). The full document usually includes a “Financial Highlights” table that lists EPS, revenue, net income, and other key metrics, as well as a commentary on whether the results met, beat, or missed analyst forecasts.
  
• Check earnings call materials – the company’s Q2 2025 earnings call transcript often contains a “Management Discussion & Analysis” section where executives explicitly state how the EPS compares to consensus estimates.
  
• Consult analyst consensus sources – platforms such as Yahoo Finance, Bloomberg, or Thomson Reuters provide the average EPS estimate that analysts were expecting for the quarter. Comparing the company’s actual EPS to that consensus will tell you if the result was “in line with,” “above,” or “below” expectations.

Summary

• EPS figure: Not included in the excerpt you shared.
  
• Alignment with expectations: Not determinable from the provided text.
  

Recommendation: Retrieve the complete MariMed Q2 2025 earnings release (or the accompanying earnings call transcript) and, if needed, cross‑reference analyst consensus estimates from a financial data service to answer the question definitively.